PU.1 and Haematopoietic Cell Fate: Dosage Matters
- PMID: 21845190
- PMCID: PMC3154517
- DOI: 10.1155/2011/808524
PU.1 and Haematopoietic Cell Fate: Dosage Matters
Abstract
The ETS family transcription factor PU.1 is a key regulator of haematopoietic differentiation. Its expression is dynamically controlled throughout haematopoiesis in order to direct appropriate lineage specification. Elucidating the biological role of PU.1 has proved challenging. This paper will discuss how a range of experiments in cell lines and mutant and transgenic mouse models have enhanced our knowledge of the mechanisms by which PU.1 drives lineage-specific differentiation during haematopoiesis.
Figures
References
-
- Moreau-Gachelin F, Tavitian A, Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature. 1988;331(6153):277–280. - PubMed
-
- DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 2000;288(5470):1439–1441. - PubMed
-
- Kastner P, Chan S. PU.1: a crucial and versatile player in hematopoiesis and leukemia. International Journal of Biochemistry and Cell Biology. 2008;40(1):22–27. - PubMed
-
- Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265(5178):1573–1577. - PubMed
LinkOut - more resources
Full Text Sources
